GlucoTrack Historical Cash Flow
| GCTK Stock | USD 0.24 0.01 4.00% |
Analysis of GlucoTrack cash flow over time is an excellent tool to project GlucoTrack future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 97.3 K or Begin Period Cash Flow of 2.5 M as it is a great indicator of GlucoTrack ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining GlucoTrack latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GlucoTrack is a good buy for the upcoming year.
GlucoTrack |
About GlucoTrack Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in GlucoTrack balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which GlucoTrack's non-liquid assets can be easily converted into cash.
GlucoTrack Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from GlucoTrack's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into GlucoTrack current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.At this time, GlucoTrack's Total Cashflows From Investing Activities is quite stable compared to the past year. Change To Netincome is expected to rise to about 616.2 K this year, although the value of Other Cashflows From Financing Activities will most likely fall to 8,294.
GlucoTrack cash flow statement Correlations
Click cells to compare fundamentals
GlucoTrack Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GlucoTrack cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 326.0K | 9.4M | (3.8M) | (3.8M) | 2.2M | 2.3M | |
| Stock Based Compensation | 512.4K | 22K | 223K | 439K | 281K | 401.1K | |
| Free Cash Flow | (3.9M) | (3.6M) | (3.8M) | (3.7M) | (6.6M) | (6.2M) | |
| Change In Working Capital | (953.5K) | (1.0M) | (53K) | 184K | 190K | 97.3K | |
| Begin Period Cash Flow | 149.7K | 476K | 9.9M | 6.1M | 2.3M | 2.5M | |
| Other Cashflows From Financing Activities | 33.5K | (53K) | (1K) | 1K | 8.7K | 8.3K | |
| Depreciation | 50.6K | 47K | 42K | 23K | 13K | 12.4K | |
| Other Non Cash Items | 7.6K | 160K | 44K | 60K | 55K | 57.8K | |
| Capital Expenditures | 5.4K | 23.4K | 53K | 5K | 1K | 0.0 | |
| Total Cash From Operating Activities | (3.9M) | (3.5M) | (3.8M) | (3.7M) | (6.6M) | (6.2M) | |
| Net Income | (3.5M) | (2.7M) | (4.1M) | (4.4M) | (7.1M) | (7.5M) | |
| Total Cash From Financing Activities | 5.0M | 4.2M | 13.0M | 0.0 | 8.7M | 4.7M | |
| End Period Cash Flow | 475.7K | 9.9M | 6.1M | 2.3M | 4.5M | 2.9M | |
| Change To Inventory | 953.0 | (85K) | 293K | 299K | 343.9K | 361.0K | |
| Change To Account Receivables | (19.3K) | 89.3K | (44.0K) | 10K | 68K | 0.0 | |
| Total Cashflows From Investing Activities | (23K) | (53K) | (1K) | 1K | 1.2K | 1.2K | |
| Change To Operating Activities | (310K) | (245K) | (157K) | 110K | 99K | 87.8K | |
| Change To Netincome | 519K | 182K | 309K | 499K | 449.1K | 616.2K | |
| Change To Liabilities | (600K) | (714K) | (257K) | 74K | 66.6K | 69.9K | |
| Investments | (23.4K) | (53K) | (1K) | 1K | 5K | 5.3K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Return On Assets (1.57) | Return On Equity (5.41) |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.